The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D002273:Carcinogens; D002699:Chlorambucil / Q000633:toxicity; D003520:Cyclophosphamide / Q000633:toxicity; D003606:Dacarbazine / Q000633:toxicity; D003609:Dactinomycin / Q000633:toxicity; D004052:Diethylnitrosamine / Q000633:toxicity; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000633:toxicity; D051379:Mice; D008927:Mitobronitol / Q000633:toxicity; D008936:Mitolactol / Q000633:toxicity; D008937:Mitomycins / Q000633:toxicity; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009588:Nitrogen Mustard Compounds / Q000633:toxicity; D010848:Picolinic Acids / Q000633:toxicity; D011344:Procarbazine / Q000633:toxicity; D051381:Rats; D013311:Streptozocin / Q000633:toxicity; D014499:Uracil Mustard / Q000633:toxicity
D000970:Antineoplastic Agents; D002273:Carcinogens; D008937:Mitomycins; D009588:Nitrogen Mustard Compounds; D010848:Picolinic Acids; D002699:Chlorambucil; D003609:Dactinomycin; D011344:Procarbazine; D004052:Diethylnitrosamine; D008927:Mitobronitol; D013311:Streptozocin; D003606:Dacarbazine; D003520:Cyclophosphamide; D008936:Mitolactol; D008558:Melphalan; D014499:Uracil Mustard